Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of breathing discomfort and respiratory sequelae in patients with post-acute sequelae of SARS-CoV-2 infection (PASC)

TY - JOUR

T1 - Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of breathing discomfort and respiratory sequelae in patients with post-acute sequelae of SARS-CoV-2 infection (PASC)

AU - Maley, Jason H.

AU - Alba, George A.

AU - Barry, John T.

AU - Bartels, Matthew N.

AU - Fleming, Talya K.

AU - Oleson, Christina V.

AU - Rydberg, Leslie

AU - Sampsel, Sarah

AU - Silver, Julie K.

AU - Sipes, Sabrina

AU - Verduzco-Gutierrez, Monica

AU - Wood, Jamie

AU - Zibrak, Joseph D.

AU - Whiteson, Jonathan

N1 - Funding Information: Dr. George Alba has a patent pending for a novel antibody, unrelated to the present work, and owns stock in Vertex Pharmaceuticals. Dr. Matthew Bartels reports grants from the National Institutes of Health (NIH) and AposTherapy, unrelated to the present work. Dr Matthew Bartels is a consultant to EHE Medical, LIH Medical, and Neofect Corporation. Sarah Sampsel is a consultant paid by AAPM&R for writing and project management. Dr. Jamie Wood is a non‐financial advisor to Statis, a company mentioned in the manuscript as an option for breathwork training. Unrelated to this work, Dr. Julie Silver participates in research funded by the Binational Scientific Foundation and is a Venture Partner at Third Culture Capital. Funding Information: The content of this Multi-Disciplinary Consensus Guidance Statement was developed in consultation with the American Academy of Physical Medicine and Rehabilitation (AAPM&R) PASC Multi-Disciplinary Collaborative, comprising 34 PASC Clinics (www.aapmr.org/PASC-guidance) that contributed to the development of the consensus statements via individuals working in their Post COVID/PASC Clinics or from their unique expertise in the assessment and treatment of PASC in their personal, expert capacity. The views and opinions expressed by Collaborative participants are their own and do not reflect the view of any organization. This Statement reflects a Writing Group collaboration, where the clinical lead is listed as the first author and writing group members are listed alphabetically; this is not a reflection of seniority or contribution level. This Consensus Guidance Statement reflects input from patient communities, and the authors thank the following organizations and individuals for their input during the Collaborative writing process: the Patient-Led Research Collaborative, Angela Meriquez Vazquez, MSW, Long Covid Patient and Advocate, and Lauren Nichols, Long Covid Patient and Chronic Illness Advocate. The authors would like to specifically acknowledge the contributions of the PASC Collaborative Co-Chairs: Dr. Ben Abramoff and Dr. Eric Herman. We would also like to acknowledge and extend a special thank you to Kavitha Neerukonda and Michael Graves, AAPM&R, for their relentless efforts in the formation of the PASC Collaborative and directing the constantly evolving aspects of this work.

PY - 2022/1

Y1 - 2022/1

UR - https://www.scopus.com/pages/publications/85123437328

UR - https://www.scopus.com/pages/publications/85123437328#tab=citedBy

U2 - 10.1002/pmrj.12744

DO - 10.1002/pmrj.12744

M3 - Article

C2 - 34902224

AN - SCOPUS:85123437328

SN - 1934-1482

VL - 14

SP - 77

EP - 95

JO - PM and R

JF - PM and R

IS - 1

ER -